窄谱与宽谱中波紫外线光疗治疗成人中重度特应性皮炎的随机对照试验
该平行组随机对照试验纳入69例对局部糖皮质激素治疗无效的成人中重度特应性皮炎患者,比较宽谱与窄谱UVB光疗的疗效与安全性。12周时两组EASI评分改善相似,调整后组间差为-0.7(95%CrI -5.6至4.1),窄谱UVB耐受性更好。
要点
- 窄谱与宽谱UVB治疗12周EASI改善相似,组间差-0.7(95%CrI -5.6至4.1)。
- 宽谱UVB组4例因不良事件退出光疗,窄谱UVB组无退出。
- vIGA、POEM、PP-NRS、DLQI及RECAP等次要结局组间无显著差异。
核心结论
- 窄谱与宽谱UVB治疗成人中重度特应性皮炎疗效相似。
- 窄谱UVB耐受性更好。
研究设计与样本
- 平行组随机对照试验,纳入≥18岁且对局部糖皮质激素治疗无效的中重度特应性皮炎患者。
- 参与者对治疗盲法,治疗和评估临床医生非盲。
- 主要结局为12周EASI评分变化。
- 试验注册号NCT04818138。
主要发现
- 宽谱UVB组EASI平均变化-8.1(95%CrI -12.1至-4.1),窄谱UVB组-8.9(95%CrI -13.0至-4.9)。
- 调整分析中,EASI变化组间差-0.7(95%CrI -5.6至4.1)。
- vIGA、POEM、PP-NRS、DLQI及RECAP组间无显著差异。
- 宽谱UVB组4例因不良事件退出光疗,窄谱UVB组无退出。
关键数值与推荐
- 主要结局为12周EASI评分变化。
- 次要结局包括vIGA-ADTM达到0或1且改善≥2、POEM、PP-NRS、DLQI及RECAP变化。
临床怎么用
- 对于成人中重度特应性皮炎,窄谱与宽谱UVB均可作为光疗选择。
- 鉴于窄谱UVB耐受性更好,可优先考虑窄谱UVB。
局限性
- 治疗和评估临床医生非盲。
- 研究仅纳入加拿大两个医院光疗单位,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ultraviolet B (UVB) phototherapy is recommended in clinical guidelines for atopic dermatitis, but it is uncertain whether narrowband or broadband UVB is more effective and better tolerated. OBJECTIVES: To compare, in a parallel-group randomized clinical trial, the efficacy and safety of broadband with narrowband UVB for the treatment of moderate-to-severe atopic dermatitis. METHODS: Participants were aged ≥ 18 years and had moderate-to-severe atopic dermatitis that was refractory to topical corticosteroid treatment. Participants were randomized 1 : 1 via a centralized computer randomization scheme to full-body broadband or narrowband UVB phototherapy, with ongoing concomitant topical therapy. Participants were blinded to the treatment, but the treating and assessing clinicians were not. The primary outcome was change in Eczema Area and Severity Index (EASI) at 12 weeks. Secondary outcomes included achieving 0 or 1 and an improvement of ≥ 2 on the validated Investigator Global Assessment for Atopic Dermatitis scale (vIGA-ADTM) and change in Patient-Oriented Eczema Measure (POEM), Peak Pruritus Numeric Rating Scale (PP-NRS), Dermatology Life Quality Index (DLQI) and Recap of atopic eczema (RECAP). Efficacy analyses were conducted on a modified intention-to-treat (ITT) population, including all randomized participants who received at least one dose of phototherapy. The trial was registered with ClinicalTrials.gov (NCT04818138). RESULTS: Thirty-four participants were randomized to broadband UVB and 35 to narrowband UVB. Thirty-two participants received at least one dose of broadband UVB and 34 received at least one dose of narrowband UVB and were included in the modified ITT analysis. The mean (SD) patient age was 37.1 (15.9) years in the broadband UVB arm and 33.2 (12.1) in the narrowband UVB arm. The mean change in EASI score in the broadband UVB arm was -8.1 [95% credible interval (CrI) -12.1 to -4.1] and in the narrowband UVB arm it was -8.9 (95% CrI -13.0 to -4.9). In the adjusted analysis, the difference between arms in change in EASI was -0.7 (95% CrI -5.6 to 4.1). There were no significant differences between arms for vIGA, POEM, PP-NRS, DLQI or RECAP. Four patients withdrew from phototherapy due to adverse events in the broadband arm; none withdrew from the narrowband arm. CONCLUSIONS: In this study, broadband and narrowband UVB were similarly effective for the treatment of moderate-to-severe atopic dermatitis. Narrowband UVB was better tolerated. Eczema is a common skin disease. It is also called ‘atopic dermatitis’. It causes inflamed, itchy skin. One treatment option for people with moderate-to-severe eczema can be light therapy. This involves using controlled ultraviolet (UV) light to relieve itching and reduce inflammation. Two types of light therapy are commonly used to treat eczema. These are narrowband UVB and broadband UVB. It is unknown which works better for treating eczema. In this study, we tested this. Our study involved 69 adults living with moderate-to-severe eczema. They were recruited from two hospital-based light therapy units in Canada. We randomly assigned (like flipping a coin) the participants to receive either narrowband or broadband UVB. When we looked at the groups after treatment, we found that the two treatments were similarly effective in clearing patches of eczema and improving the symptoms. More people had side effects with broadband UVB that led to them stopping the treatment. Our findings suggest that narrowband and broadband UVB were similarly effective in treating eczema in adults. Narrowband UVB appeared to be better tolerated by patients.
引用
- Drucker AM, Zhong Y, Tomlinson G, et al. Narrowband versus broadband ultraviolet B phototherapy for adults with moderate-to-severe atopic dermatitis: a randomized controlled trial. Br J Dermatol. 2026. PMID: 42035246. doi:10.1093/bjd/ljag161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。